Laman UtamaCHGCY • OTCMKTS
add
Chugai Pharmaceutical ADR
Tutup sebelumnya
$22.65
Julat hari
$22.11 - $23.53
Julat tahun
$19.50 - $31.26
Permodalan pasaran
11.25T JPY
Bilangan Purata
198.76K
Nisbah P/E
-
Hasil dividen
-
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (JPY) | Jun 2025info | Perubahan T/T |
|---|---|---|
Hasil | 290.00B | -8.20% |
Perbelanjaan pengendalian | 65.24B | -6.32% |
Pendapatan bersih | 97.16B | -13.15% |
Margin untung bersih | 33.50 | -5.39% |
Pendapatan bagi setiap syer | — | — |
EBITDA | 137.09B | -13.63% |
Kadar cukai berkesan | 28.56% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (JPY) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 1.03T | 25.99% |
Jumlah aset | 2.28T | 10.59% |
Jumlah liabiliti | 293.22B | -4.94% |
Jumlah ekuiti | 1.99T | — |
Syer tertunggak | 1.65B | — |
Harga kepada buku | 0.02 | — |
Pulangan pada aset | 15.47% | — |
Pulangan pada modal | 17.56% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (JPY) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 97.16B | -13.15% |
Tunai daripada operasi | 119.41B | 69.01% |
Tunai daripada pelaburan | -46.58B | 66.88% |
Tunai daripada pembiayaan | -2.46B | 5.08% |
Perubahan bersih dalam tunai | 73.67B | 206.61% |
Aliran tunai bebas | — | — |
Perihal
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
CEO
Diasaskan
10 Mac 1925
Tapak web
Pekerja
5,026
